Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. INTC
2. DECK
3. AMD
4. INFY
5. RNG
6. UNP
7. DGX
8. ACI
9. URI
10. ARGX

Go back to Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension
GALECTIN (NASDAQ: GALT) Delayed: 3.45 --0 (-0%)
Previous Close $3.45    52 Week High $3.05 
Open $3.45    52 Week Low $0.49 
Day High $3.45    P/E N/A 
Day Low $3.45    EPS $-1.32 
Volume 418